CN105378481A - 微流体协同酶增强反应性ceer免疫测定法 - Google Patents

微流体协同酶增强反应性ceer免疫测定法 Download PDF

Info

Publication number
CN105378481A
CN105378481A CN201480039207.8A CN201480039207A CN105378481A CN 105378481 A CN105378481 A CN 105378481A CN 201480039207 A CN201480039207 A CN 201480039207A CN 105378481 A CN105378481 A CN 105378481A
Authority
CN
China
Prior art keywords
microcarrier
coding
methods according
antibody
signal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201480039207.8A
Other languages
English (en)
Chinese (zh)
Inventor
I·塞韦里尼
K·玛高诺瓦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
Original Assignee
Societe dAssistance Technique pour Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dAssistance Technique pour Produits Nestle SA filed Critical Societe dAssistance Technique pour Produits Nestle SA
Publication of CN105378481A publication Critical patent/CN105378481A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
CN201480039207.8A 2013-07-09 2014-06-30 微流体协同酶增强反应性ceer免疫测定法 Pending CN105378481A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361844308P 2013-07-09 2013-07-09
US61/844,308 2013-07-09
PCT/EP2014/063846 WO2015003945A1 (fr) 2013-07-09 2014-06-30 Essai immunologique microfluidique à réactivité renforcée par collaboration enzymatique ceer

Publications (1)

Publication Number Publication Date
CN105378481A true CN105378481A (zh) 2016-03-02

Family

ID=51022887

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480039207.8A Pending CN105378481A (zh) 2013-07-09 2014-06-30 微流体协同酶增强反应性ceer免疫测定法

Country Status (7)

Country Link
EP (1) EP3019867A1 (fr)
JP (1) JP2016527495A (fr)
KR (1) KR20160026909A (fr)
CN (1) CN105378481A (fr)
AU (1) AU2014289499A1 (fr)
CA (1) CA2912318A1 (fr)
WO (1) WO2015003945A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107190050A (zh) * 2016-03-14 2017-09-22 华东理工大学 一种hrp活性测定及h2o2浓度检测的试剂盒及其应用
CN114728169A (zh) * 2019-09-23 2022-07-08 麦考瑞大学 tau蛋白病的治疗

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102666117B1 (ko) * 2018-11-26 2024-05-16 주식회사 엘지화학 다중 면역 진단 기기
CN112574284B (zh) * 2020-12-29 2023-08-08 珠海碳云诊断科技有限公司 多肽、其组合物、包含其的试剂盒及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1566951A (zh) * 2003-06-16 2005-01-19 中国科学院大连化学物理研究所 一种基于微流控芯片的细胞分选方法及其专用芯片
CN101563609A (zh) * 2006-09-21 2009-10-21 普罗米修斯实验室股份有限公司 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列
CN102264474A (zh) * 2008-12-23 2011-11-30 比奥卡尔齐什股份有限公司 用于进行生物学检测的检测设备和方法
WO2013033623A1 (fr) * 2011-09-02 2013-03-07 Nestec S.A. Profilage de protéines de voie de signalisation pour déterminer une efficacité thérapeutique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532138A (en) 1990-04-26 1996-07-02 Behringwerke Ag Method and kits for determining peroxidatively active catalysts
US5332662A (en) 1992-07-31 1994-07-26 Syntex (U.S.A.) Inc. Methods for determining peroxidatively active substances
DE69417242T2 (de) 1993-09-03 1999-07-08 Behringwerke Ag Fluoreszenz-sauerstoffkanalisation-immunteste
US8409877B2 (en) * 2006-12-29 2013-04-02 Intel Corporation Enzymatic signal generation and detection of binding complexes in stationary fluidic chip
CN102016581B (zh) 2008-02-25 2014-07-30 雀巢产品技术援助有限公司 用抗体阵列选择乳腺癌治疗药物
US20120149128A1 (en) * 2009-02-23 2012-06-14 Victor Manneh Assays and assay devices
EP2312393A1 (fr) 2009-10-14 2011-04-20 Biocartis SA Procédé pour la production de microparticules
EP2484447A1 (fr) 2011-02-07 2012-08-08 Biocartis SA Micro-supports codés améliorés, système d'analyse les utilisant et procédé d'exécution d'une analyse
WO2013055829A1 (fr) * 2011-10-11 2013-04-18 Nestec S.A. Dosage de proximité pour la détection de l'expression et de l'activation de protéines de signalisation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1566951A (zh) * 2003-06-16 2005-01-19 中国科学院大连化学物理研究所 一种基于微流控芯片的细胞分选方法及其专用芯片
CN101563609A (zh) * 2006-09-21 2009-10-21 普罗米修斯实验室股份有限公司 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列
CN102264474A (zh) * 2008-12-23 2011-11-30 比奥卡尔齐什股份有限公司 用于进行生物学检测的检测设备和方法
WO2013033623A1 (fr) * 2011-09-02 2013-03-07 Nestec S.A. Profilage de protéines de voie de signalisation pour déterminer une efficacité thérapeutique

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107190050A (zh) * 2016-03-14 2017-09-22 华东理工大学 一种hrp活性测定及h2o2浓度检测的试剂盒及其应用
CN107190050B (zh) * 2016-03-14 2020-10-27 华东理工大学 一种hrp活性测定及h2o2浓度检测的试剂盒及其应用
CN114728169A (zh) * 2019-09-23 2022-07-08 麦考瑞大学 tau蛋白病的治疗

Also Published As

Publication number Publication date
WO2015003945A1 (fr) 2015-01-15
JP2016527495A (ja) 2016-09-08
CA2912318A1 (fr) 2015-01-15
AU2014289499A1 (en) 2015-11-19
KR20160026909A (ko) 2016-03-09
EP3019867A1 (fr) 2016-05-18

Similar Documents

Publication Publication Date Title
US20220082559A1 (en) Systems and methods for performing immunoassays
Yu et al. Protein microarrays for personalized medicine
US20200158731A1 (en) Lung cancer biomarkers
JP6317771B2 (ja) 電気泳動分離装置およびそれを使用するための方法
Chung et al. Nanoparticle detection of urinary markers for point-of-care diagnosis of kidney injury
WO2019196270A1 (fr) Système de détection de micro-nanoparticules et procédé associé
US11802877B2 (en) Lung cancer biomarkers
JP2007527527A (ja) 多重化アッセイにおいて個々の分析物の定量範囲を調整するための方法
JP2014500503A (ja) 精神神経疾患の処置をモニタリングするためのバイオマーカー
Iqbal et al. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation
CN105378481A (zh) 微流体协同酶增强反应性ceer免疫测定法
Chan et al. Prostate cancer detection: A systematic review of urinary biosensors
Yoo et al. Ultra-sensitive detection of brain-derived neurotrophic factor (BDNF) in the brain of freely moving mice using an interdigitated microelectrode (IME) biosensor
US20220397528A1 (en) Systems and methods for rapid, sensitive multiplex immunoassays
Hwang et al. Aptamer-conjugated live human immune cell based biosensors for the accurate detection of C-reactive protein
Shohatee et al. Hydrogel-based suspension array for biomarker detection using horseradish peroxidase-mediated silver precipitation
US20170089912A1 (en) Collaborative enzyme enhanced reactive (ceer) immunoassay using flow cytometry
Vashist Trends in multiplex immunoassays for in vitro diagnostics and point-of-care testing
US20160131643A1 (en) Microfluidic collaborative enzyme enhanced reactive ceer immunoassay
Chen et al. Upconversion nanoparticle‐assisted single‐molecule assay for detecting circulating antigens of aggressive prostate cancer
Gallotta et al. Biomarkers quantification with antibody arrays in cancer early detection
Hwang et al. Evaluation of analytical performances of magnetic force-assisted electrochemical sandwich immunoassay for the quantification of carcinoembryonic antigen
US20230341422A1 (en) A Home Test for Measuring Glucose Control and Kidney Function in Patients
Zhang et al. Label-free biosensor for non-invasive and low-cost detection of metastatic risk through urine biopsy
Mousavi et al. A Simple Aptamer-Based Nanoconjugate Assay for Diagnosis of Chronic Myeloid Leukemia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20160302